Author: Jishnu Nair

A battery recycling company, which is planning Texas facilities, would be valued at $250 million in a deal with a special purpose acquisition company.

The South Korea-based pharmaceutical company is back in Houston after participating in investments into Axiom Space.

The regulatory agency charged Kiromic Biopharma and its former CEO and CFO for their roles in disclosures related to drug candidates’ FDA status.

Marker Therapeutics recently sold some manufacturing assets and has seen top executive turnover between its last fundraising and now.

Houston-area medical device manufacturer Velentium is a fast-growing company that helped produce respirators during the Covid-19 pandemic.

Since taking over as CEO, KBR CEO Stuart Bradie has overseen the company’s overhaul from its oil and gas background to “markets of the future.”

Several Houston technology firms filed Form Ds with the Securities and Exchange Commission in November, disclosing millions of dollars raised.

The arrival of Plug and Play in Sugar Land is part of a trend of cities outside Houston investing in startup communities.

The Cancer Prevention and Research Institute of Texas issued approximately $89 million in funding, with much of that benefiting Houston.

The Texas Medical Center has spent more in venture investment this year than any other, and companies are moving its way.